DG
Therapeutic Areas
Harvard Apparatus Regenerative Technology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cellspan Esophageal Implant (CEI) | Long-Gap Esophageal Atresia | Phase 1 |
Leadership Team at Harvard Apparatus Regenerative Technology
JH
Jerry He
Chief Executive Officer & Chairman of the Board
HY
Hong Yu
President
JD
Joseph Damasio, Jr.
Chief Financial Officer
WF
William Fodor
Chief Scientific Officer
JJ
Jason Jing Chen
Vice Chairman of the Board
TL
Ting Li
Director
SF
Stephen F. Badylak
Chairman, Scientific & Clinical Advisory Board